BridgeMD
New treatment option for Prematurity
Official title Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
ClinicalTrials.gov ID: NCT06420531
What this study is testing
- What it's testing
- The goal of this multi-center randomized, parallel group trial is to determine the effect of human milk diets ranging between 180 and 200 mL/kg/day on the body composition outcomes of moderately preterm infants born between 27 and 31 weeks of gestation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 4
You may be able to join if
- Gestational age between 27 0/7 and 31 6/7 weeks
- Birthweight of 1500 grams or less
- Human milk feeding during the first 14 days after birth
- Full enteral feeding (120mL/kg/day or more) within the first 14 days after birth
You likely can't join if
- Necrotizing enterocolitis stage 2 or greater
- Spontaneous intestinal perforation
- Major congenital/chromosomal anomalies
- Terminal illness requiring limited or withheld support
- Intention to restrict fluid intake after the first 14 postnatal days due to the presence of a symptomatic patent ductus arteriosus (PDA)
- Any formula feeding within the first 14 days after birth
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Jackson, Mississippi, United States
- Dallas, Texas, United States
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 hours to 4 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Jackson, Mississippi, United States; Dallas, Texas, United States; Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.